| abstract |
The present invention administers to a subject in need of treatment an effective amount of a sustained release composition comprising a biocompatible polymer having a biologically active labile agent incorporated therein, and a corticosteroid A method for in vivo sustained release of a biologically active labile agent, wherein the labile agent is released for a period of at least about 2 weeks. It is understood that the corticosteroid is present in an amount sufficient to modulate the release profile of the biologically active labile drug from the sustained release composition. Also disclosed are pharmaceutical compositions suitable for use in the methods of the invention. |